UI
The startup develops a computational platform that utilizes machine learning and protein engineering to identify peptide sequences for protein-modulating therapies. This technology enables the pharmaceutical industry to target previously difficult proteins and create new treatments for a broader range of diseases through AI-driven protein modulation and programmable protein degradation.
Updated 3 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a computational platform that utilizes machine learning and protein engineering to identify peptide sequences for protein-modulating therapies. This technology enables the pharmaceutical industry to target previously difficult proteins and create new treatments for a broader range of diseases through AI-driven protein modulation and programmable protein degradation.